Treatment of chronic periodontitis decreases serum prohepcidin levels in patients with chronic kidney disease

Clinics

Volumn 66, Issue 4, 2011, Pages 657-662

  Vilela, Eduardo Machado ^a   Bastos, Jessica Amaral ^b   Fernandes, Natalia ^a   Ferreira, Ana Paula ^a   Chaoubah, Alfredo ^a   Bastos, Marcus Gomes ^a  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^b Department of Dentistry   (Brazil)

Author keywords

Hronic kidney disease; Hronic periodontitis; Inflammatory markers; Periodontal treatment; Prohepcidin

Indexed keywords

EID: 79958700293     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322011000400022     Document Type: Article

References (26)

1. Abensur H, Bastos MG, Canziani MEF. Aspectos atuais da anemia na doença renal crônica. J Bras Nefrol. 2006;28:104-107.
2. K/DOQI. National Kidney Foundation. Definition and classification of stages of chronic kidney disease. Am J Kidney Dis. 2002;39:S46-S75.
3. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090-2093, doi: 10.1126/science.1104742.
4. Malyszko J, Malyszko JS, Hryszko T, Pawlak K, Mysliwiec M. Is hepcidin a link between anemia, inflammation and liver function in hemodialysed patients? Am J Nephrol. 2005;25:586-590.
5. Krause A, Neitz S, Mägert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 2000;480:147-150, doi: 10.1016/S0014-5793(00)01920-7.
6. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001; 276:7806-7810.
7. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002;110:1037-1044.
8. Ganz T. Molecular control of iron transport. J Am Soc Nephrol. 2007; 18:394-400, doi: 10.1681/ASN.2006070802.
9. Kshirsagar AV, Offenbacher S, Moss KL, Barros SP, Beck JD. Antibodies to periodontal organisms are associated with decreased kidney function. The dental atherosclerosis risk in communities study. Blood Purif. 2007; 25:125-132, doi: 10.1159/000096411.
10. D'Aiuto F, Ready D, Tonetti MS. Periodontal disease and C-reactive protein- associated cardiovascular risk. J Periodontal Res. 2004; 39:236-241, doi: 10.1111/j.1600-0765.2004.00731.x.
11. Ide M, McPartlin D, Coward PY, Crook M, Lumb P, Wilson RF. Effect of treatment of chronic periodontitis on levels of serum markers of acutephase inflammatory and vascular responses. J Clin Periodontol. 2003; 30:334-340, doi: 10.1034/j.1600-051X.2003.00282.x.
12. Craig RG, Kotanko P, Kamer AR, Levin NW. Periodontal diseases: a modifiable source of systemic inflammation for the end-stage renal disease patient on haemodialysis therapy? Nephrol Dial Transplant. 2007;22:312-315, doi: 10.1093/ndt/gfl604.
13. Marcaccini AM, Meschiari CA, Sorgi CA, Saraiva MCP, Souza AM, Faccioli LH, et al. Circulation interleukin-6 and high-sensitivity Creactive protein decrease after periodontal therapy in otherwise healthy subjects. J Periodontol. 2009;80:594-602, doi: 10.1902/jop.2009.080561.
14. Fisher MA, Taylor GW. A prediction model for chronic kidney disease includes periodontal disease. J Periodontol. 2009;80:16-23, doi: 10.1902/jop.2009.080226.
15. Machtei EE, Christersson LA, Grossi SG, Dunford R, Zambon JJ, Genco RJ. Clinical criteria for the definition of established periodontitis. J Periodontol. 1992;63:206-214.
16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130:461-470.
17. Libby P, Ridker PM, Maseri A. Inflamation and atherosclerosis. Circulation. 2002;105:1135-1143, doi: 10.1161/hc0902.104353.
18. Pihlstrom BI, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005;366:1809-1820, doi: 10.1016/S0140-6736(05)67728-8.
19. Paraskevas S, Huizinga JD, Loss BG. A systematic review and metaanalyses on C-reactive protein in relation to periodontitis. J Clin Periodontol. 2008;35:277-279, doi: 10.1111/j.1600-51X.2007.01173.x.
20. Higashi Y, Goto C, Jitsuiki D, Umemura T, Nishioka K, Hidaka T, et al. Periodontal infection is associated with endothelial dysfunction in healthy subjects and hypertensive patients. Hypertension. 2008; 51:446-453, doi: 10.1161/HYPERTENSIONAHA.107.101535.
21. Tonetti MS, D'Aiuto F, Nibali L, Donald A, Storry C, Parkar M, et al. Treatment of periodontitis and endotelial function. N Eng J Med. 2007; 356:911-920.
22. Zaritsky J, Young B, Wang HJ, Westerman M, Olbina G, Nemeth E, et al. Hepcidin--a potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol. 2009;4:1051-1056, doi: 10.2215/CJN.05931108.
23. Malyszko J, Malyszko JS, Mysliwiec M. A possible role of hepcidin in the pathogenesis of anemia among kidney allograft recipients. Transplant Proc. 2009;41:3056-3059, doi: 10.1016/j.transproceed.2009.08.003.
24. Kato A, Tsuji T, Luo J, Sakao Y, Yasuda H, Hishida A. Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients. Am J Nephrol. 2008;28:115-121.
25. Young B, Zaritsky J. Hepcidin for clinicians. Clin J Am Soc Nephrol. 2009;4:1384-1387, doi: 10.2215/CJN.02190309.
26. Ashby DR, Gale DP, Busbridge M, Murphy KG, Duncan ND, Cairns TD, et al. Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int. 2009;75:976-981, doi: 10.1038/ki.2009.21.